Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Precheck Program topic
No spam. Unsubscribe anytime.
Attendee asks whether precheck finalists will be public; FDA panel to follow up
Summary
An attendee representing Laura Slabs Limited asked whether the nine finalists selected April 1 for the precheck program would be publicly disclosed; the moderator said the panel would need to follow up because the responsible official was not present.
Sharath, identifying himself as representing Laura Slabs Limited, asked whether the list of nine finalists selected for the precheck program on April 1 would be made public to support domestic manufacturing. The moderator replied that they would need to get back with an answer because the responsible speaker (Dr. Rosencrantz) was not present.
The exchange did not include a substantive response on disclosure policy or timing; the panel offered to follow up after consulting the appropriate office. That response frames the question as pending rather than resolved during the session.
